Belfast Health & Social Care Trust
Contracts awarded by Belfast Health & Social Care Trust, taken from Find a Tender notices published between 3 Sept 2025 to 28 Aug 2026. Every row links to the original notice.
- Contracts awarded70
- Period covered3 Sept 2025 to 28 Aug 2026
- Distinct suppliers132
- Contract valuesMedian £2.6m across the 6 awards that state a value
- Suppliers named57 of 70 awards
What they buy
- Health & medical 48 awards
- Repair & maintenance 14 awards
- Catering & food 5 awards
- IT, software & telecoms 3 awards
- Electrical & lighting equipment 2 awards
- Laboratory & precision equipment 1 award
Contracts awarded
-
Promotional Products and Stands
21 May 2026 · ends 30 Apr 2028Awarded to PARAGON CUSTOMER COMMUNICATIONS (LONDON) LIMITED, WILD THANG LTD, BANNER GROUP LIMITED, NORTHSIDE GRAPHICS LIMITED, IMPRESS PROMOTIONAL PRODUCTS LTD, OAKDENE SERVICES (1925) LTD
-
ALTUVOCT POWDER + SOLVENT FOR SOLUTION FOR INJECTION VIAL
21 May 2026 · ends 31 Mar 2028Awarded to HEALTHNET HOMECARE (UK) LIMITED
-
ALTUVOCT POWDER + SOLVENT FOR SOLUTION FOR INJECTION VIAL
21 May 2026 · ends 31 Mar 2028Awarded to SCIENSUS PHARMA SERVICES LIMITED
-
PEGUNIGALSIDASE ALFA SOLUTION FOR INFUSION VIAL
21 May 2026 · ends 31 Mar 2028Awarded to SCIENSUS PHARMA SERVICES LIMITED
-
IDURSULFASE 6MG/3ML CONCENTRATE FOR SOLUTION FOR INFUSION
21 May 2026 · ends 31 Mar 2028Awarded to SCIENSUS PHARMA SERVICES LIMITED
-
TEZEPELUMAB 210MG/1.91ML SOLUTION FOR INJECTION PRE-FILLED DEVICE
21 May 2026 · ends 31 Mar 2028Awarded to HEALTHNET HOMECARE (UK) LIMITED
-
PANZYGA SOLUTION FOR INFUSION
21 May 2026 · ends 31 Mar 2028Awarded to SCIENSUS PHARMA SERVICES LIMITED
-
ALTUVOCT (EFANESOCTOCOG ALFA) POWDER FOR SOLUTION FOR INJECTION, 1 each
21 May 2026 · ends 31 Mar 2028Awarded to ALLOGA UK LIMITED
-
TRAMETINIB 2MG TABLETS, 30 tablet, pack
21 May 2026 · ends 31 Mar 2028Awarded to NOVARTIS PHARMACEUTICALS UK LIMITED
-
Maintenance of Sciex Liquid Chromatography Mass Spectrometer Systems
20 May 2026 · ends 31 Dec 2029Awarded to AB SCIEX UK LIMITED
-
Maintenance of Agilent Laboratory Equipment
11 May 2026 · ends 31 Jan 2030Awarded to Agilent Technologies LDA UK Limited
-
Maintenance of LithoClast Trilogly
11 May 2026 · ends 30 Apr 2030Awarded to Boston Scientific
-
QINLOCK (RIPRETINIB) 50MG TABS 90PK
8 May 2026 · ends 31 Mar 2027Awarded to ALLOGA UK LIMITED
-
BINIMETINIB 45MG 28PK
8 May 2026 · ends 31 Mar 2028Awarded to PIERRE FABRE LIMITED
-
NORMAL IMMUNOGLOBULIN HUMAN XEMBIFY SOLUTION FOR INJECTION VIAL
7 May 2026 · £680k · ends 31 Mar 2028Awarded to HEALTHNET HOMECARE (UK) LIMITED
-
Interventional and Diagnostic Cardiac Cath Lab Consumables
27 Apr 2026 · ends 31 Mar 2028Supplier not named in a form we publish
-
Maintenance of Apheresis Systems
16 Apr 2026 · ends 31 Mar 2031Awarded to TERUMO BCT LTD.
-
Automating Histopathology Sectioning with AS-410M Auto Slide preparation system
8 Apr 2026 · ends 31 Mar 2031Supplier not named in a form we publish
-
Maintenance of Bayer Injection Systems
13 Mar 2026 · ends 29 Feb 2028Awarded to BAYER PUBLIC LIMITED COMPANY
-
Bottled Water
13 Mar 2026 · ends 29 Feb 2028Supplier not named in a form we publish
-
Regulatory Peptide Reagent Kits
29 Jan 2026 · ends 1 Feb 2031Awarded to OXFORD BIOSYSTEMS LIMITED
-
Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial
21 Jan 2026 · ends 5 Jan 2030Awarded to ALMAC CLINICAL SERVICES LIMITED
-
OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack
20 Jan 2026 · terminatedAwarded to LLOYDS CLINICAL LIMITED
-
BIMEKIZUMAB (BIMZELX) HOMECARE 160 mg Pre-Filled Pen 2 Pen Pack
20 Jan 2026 · ends 31 Dec 2027Awarded to HEALTHNET HOMECARE (UK) LIMITED
-
EVKEEZA (EVINACUMAB) 345MG/2.3ML CONCENTRATE FOR SOLUTION FOR INFUSION VIAL, 2.3 mL, vial
20 Jan 2026 · terminatedAwarded to HEALTHNET HOMECARE (UK) LIMITED
Supplier names are published only where the notice carries a Companies House number, so sole traders and named individuals are not listed. Figures are counts from the published notices and nothing is inferred. To correct or remove something, email [email protected].